+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Sinusitis Drugs Market 2019-2023 - Product Image

Global Sinusitis Drugs Market 2019-2023

  • ID: 4787747
  • Report
  • June 2019
  • Region: Global
  • 124 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • CHIESI Farmaceutici Spa
  • GlaxoSmithKline Plc
  • Intersect ENT Inc.
  • Merck & Co. Inc.
  • Sanofi
  • MORE
Global Sinusitis Drugs Market: About this market

The sinusitis drugs market analysis considers the treatment of sinusitis using steroid nasal sprays, antibiotics, decongestants, and other drugs. Our analysis also considers the market’s growth in Asia, Europe, North America, and ROW. In 2018, steroid nasal sprays segment had a significant share market share, and this trend is expected to continue over the forecast period. Factors such as the higher therapeutic efficacy are playing a significant role in the steroid nasal sprays segment to maintain its market position. Also, our sinusitis drugs market looks at factors such as the rising prevalence of sinusitis, growing awareness among people about sinusitis treatment, and increasing mergers and acquisitions. However, surgical intervention for sinusitis management, unknown etiology of sinusitis, and the launch of generics may hamper the growth of the sinusitis drugs industry over the forecast period.

Global Sinusitis Drugs Market: Overview

Rising prevalence of sinusitis

Risk factors such as the history of respiratory tract infection, structural problems within the sinus glands, and nasal polyps have increased the prevalence of sinusitis in general population. Other factors, such as allergies, pollutants, and fungal infections, also cause sinus infections. In 2017, a significant number of adults in the US were diagnosed with sinusitis. The prevalence of the infection was found to be higher in males than in females. The growing prevalence of sinusitis has increased the consumption of sinusitis treatment drugs. This is one of the key factors driving the growth of the global sinusitis drugs market size at a CAGR of over 6% during the forecast period.

Emergence of novel therapeutic approaches

The growing demand for targeted drugs for sinusitis is encouraging market vendors to develop novel therapies. Some vendors in the market are developing bacteriophage therapeutics that targets Staphylococcus aureus, including its antibiotic-resistant strains. These drugs are currently in Phase I/II stage of development. The advent of many such novel therapeutic approaches is expected to fuel the growth of the global sinusitis drugs market size.

Competitive Landscape

With the presence of several players, the global sinusitis drugs market is fairly fragmented. This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several sinusitis drug companies, that include CHIESI Farmaceutici Spa, GlaxoSmithKline Plc, Intersect ENT Inc., Merck & Co. Inc., and Sanofi.

Also, the sinusitis drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CHIESI Farmaceutici Spa
  • GlaxoSmithKline Plc
  • Intersect ENT Inc.
  • Merck & Co. Inc.
  • Sanofi
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: PIPELINE ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • Steroid nasal sprays - Market size and forecast 2018-2023
  • Antibiotics - Market size and forecast 2018-2023
  • Decongestants - Market size and forecast 2018-2023
  • Other drugs - Market size and forecast 2018-2023
  • Market opportunity by product
PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity
PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 14: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • CHIESI Farmaceutici Spa
  • GlaxoSmithKline Plc
  • Intersect ENT, Inc.
  • Merck & Co., Inc.
  • Sanofi
PART 15: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
PART 16: EXPLORE

List of Exhibits
Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Some key clinical trials for sinusitis and related comorbidities
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Steroid nasal sprays - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Steroid nasal sprays - Year-over-year growth 2019-2023 (%)
Exhibit 22: Antibiotics - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Antibiotics - Year-over-year growth 2019-2023 (%)
Exhibit 24: Decongestants - Market size and forecast 2018-2023 ($ millions)
Exhibit 25: Decongestants - Year-over-year growth 2019-2023 (%)
Exhibit 26: Other drugs - Market size and forecast 2018-2023 ($ millions)
Exhibit 27: Other drugs - Year-over-year growth 2019-2023 (%)
Exhibit 28: Market opportunity by product
Exhibit 29: Customer landscape
Exhibit 30: Market share by geography 2018-2023 (%)
Exhibit 31: Geographic comparison
Exhibit 32: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: North America - Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in North America
Exhibit 35: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Europe
Exhibit 38: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in Asia
Exhibit 41: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 42: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 43: Top 3 countries in ROW
Exhibit 44: Key leading countries
Exhibit 45: Market opportunity
Exhibit 46: Impact of drivers and challenges
Exhibit 47: Vendor landscape
Exhibit 48: Landscape disruption
Exhibit 49: Vendors covered
Exhibit 50: Vendor classification
Exhibit 51: Market positioning of vendors
Exhibit 52: CHIESI Farmaceutici Spa - Vendor overview
Exhibit 53: CHIESI Farmaceutici Spa - Business segments
Exhibit 54: CHIESI Farmaceutici Spa - Organizational developments
Exhibit 55: CHIESI Farmaceutici Spa - Geographic focus
Exhibit 56: CHIESI Farmaceutici Spa - Segment focus
Exhibit 57: CHIESI Farmaceutici Spa - Key offerings
Exhibit 58: CHIESI Farmaceutici Spa - Key customers
Exhibit 59: GlaxoSmithKline Plc - Vendor overview
Exhibit 60: GlaxoSmithKline Plc - Business segments
Exhibit 61: GlaxoSmithKline Plc - Organizational developments
Exhibit 62: GlaxoSmithKline Plc - Geographic focus
Exhibit 63: GlaxoSmithKline Plc - Segment focus
Exhibit 64: GlaxoSmithKline Plc - Key offerings
Exhibit 65: GlaxoSmithKline Plc - Key customers
Exhibit 66: Intersect ENT Inc. - Vendor overview
Exhibit 67: Intersect ENT Inc. - Business segments
Exhibit 68: Intersect ENT Inc. - Organizational developments
Exhibit 69: Intersect ENT Inc. - Key offerings
Exhibit 70: Intersect ENT Inc. - Key customers
Exhibit 71: Merck & Co. Inc. - Vendor overview
Exhibit 72: Merck & Co. Inc. - Business segments
Exhibit 73: Merck & Co. Inc. - Organizational developments
Exhibit 74: Merck & Co. Inc. - Geographic focus
Exhibit 75: Merck & Co. Inc. - Segment focus
Exhibit 76: Merck & Co. Inc. - Key offerings
Exhibit 77: Merck & Co. Inc. - Key customers
Exhibit 78: Sanofi - Vendor overview
Exhibit 79: Sanofi - Business segments
Exhibit 80: Sanofi - Organizational developments
Exhibit 81: Sanofi - Geographic focus
Exhibit 82: Sanofi - Segment focus
Exhibit 83: Sanofi - Key offerings
Exhibit 84: Sanofi - Key customers
Exhibit 85: Validation techniques employed for market sizing
Exhibit 86: Definition of market positioning of vendors
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • CHIESI Farmaceutici Spa
  • GlaxoSmithKline Plc
  • Intersect ENT Inc.
  • Merck & Co. Inc.
  • Sanofi
  • MORE
The following companies are recognised as the key players in the global sinusitis drugs market: CHIESI Farmaceutici Spa, GlaxoSmithKline Plc, Intersect ENT Inc., Merck & Co. Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: “The latest trend gaining momentum in the market is the emergence of novel therapeutic approaches.”

According to the report, one of the major drivers for this market is the rising prevalence of sinusitis.

Further, the report states that one of the major factors hindering the growth of this market is the surgical intervention for sinusitis management.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • CHIESI Farmaceutici Spa
  • GlaxoSmithKline Plc
  • Intersect ENT Inc.
  • Merck & Co. Inc.
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll